Wolff Wiese Magana LLC Grows Stake in Kenvue Inc. (NYSE:KVUE)

Wolff Wiese Magana LLC lifted its stake in shares of Kenvue Inc. (NYSE:KVUE) by 0.7% in the 3rd quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 76,999 shares of the company’s stock after purchasing an additional 501 shares during the period. Kenvue accounts for 1.2% of Wolff Wiese Magana LLC’s investment portfolio, making the stock its 28th biggest holding. Wolff Wiese Magana LLC’s holdings in Kenvue were worth $1,781,000 as of its most recent filing with the Securities & Exchange Commission.

Several other large investors also recently modified their holdings of KVUE. Teachers Retirement System of The State of Kentucky bought a new position in Kenvue during the fourth quarter valued at $3,187,000. SageView Advisory Group LLC purchased a new stake in Kenvue in the 4th quarter worth about $262,000. B. Riley Wealth Advisors Inc. raised its stake in Kenvue by 7.0% in the 4th quarter. B. Riley Wealth Advisors Inc. now owns 27,210 shares of the company’s stock valued at $586,000 after acquiring an additional 1,770 shares during the period. CWM LLC lifted its holdings in Kenvue by 9.8% during the first quarter. CWM LLC now owns 34,582 shares of the company’s stock valued at $742,000 after purchasing an additional 3,094 shares during the last quarter. Finally, NBC Securities Inc. boosted its position in Kenvue by 8.4% during the first quarter. NBC Securities Inc. now owns 11,301 shares of the company’s stock worth $242,000 after purchasing an additional 879 shares during the period. Hedge funds and other institutional investors own 97.64% of the company’s stock.

Analyst Upgrades and Downgrades

Several analysts have recently issued reports on the stock. Royal Bank of Canada lowered shares of Kenvue from an “outperform” rating to a “sector perform” rating and set a $24.00 price target on the stock. in a research report on Tuesday, September 24th. Jefferies Financial Group started coverage on Kenvue in a research report on Tuesday, September 24th. They set a “buy” rating and a $27.00 target price on the stock. Piper Sandler lifted their price target on Kenvue from $20.00 to $21.00 and gave the company a “neutral” rating in a research report on Monday, September 23rd. Citigroup decreased their price objective on Kenvue from $21.00 to $20.00 and set a “neutral” rating on the stock in a research note on Wednesday, July 10th. Finally, UBS Group raised their target price on Kenvue from $20.00 to $22.00 and gave the stock a “neutral” rating in a research note on Wednesday, August 7th. One research analyst has rated the stock with a sell rating, seven have issued a hold rating and three have given a buy rating to the stock. According to MarketBeat, Kenvue has an average rating of “Hold” and a consensus price target of $22.20.

Kenvue Price Performance

Kenvue stock opened at $21.73 on Thursday. The stock has a market cap of $41.61 billion, a price-to-earnings ratio of 27.86, a PEG ratio of 2.76 and a beta of 1.40. The company has a quick ratio of 0.68, a current ratio of 0.99 and a debt-to-equity ratio of 0.69. The business has a 50-day simple moving average of $22.24 and a 200 day simple moving average of $20.19. Kenvue Inc. has a 52 week low of $17.67 and a 52 week high of $23.55.

Kenvue (NYSE:KVUE) last issued its quarterly earnings data on Tuesday, August 6th. The company reported $0.32 EPS for the quarter, topping the consensus estimate of $0.28 by $0.04. The company had revenue of $4 billion during the quarter, compared to analyst estimates of $3.93 billion. Kenvue had a return on equity of 21.80% and a net margin of 7.23%. Kenvue’s revenue was down .3% on a year-over-year basis. During the same quarter in the previous year, the firm earned $0.32 earnings per share. On average, research analysts forecast that Kenvue Inc. will post 1.08 earnings per share for the current fiscal year.

Kenvue Increases Dividend

The business also recently disclosed a quarterly dividend, which was paid on Wednesday, August 28th. Stockholders of record on Wednesday, August 14th were given a dividend of $0.205 per share. The ex-dividend date was Wednesday, August 14th. This represents a $0.82 annualized dividend and a dividend yield of 3.77%. This is a boost from Kenvue’s previous quarterly dividend of $0.20. Kenvue’s dividend payout ratio (DPR) is 105.13%.

About Kenvue

Kenvue Inc operates as a consumer health company worldwide. The company operates through three segments: Self Care, Skin Health and Beauty, and Essential Health. The Self Care segment offers cough, cold and allergy, pain care, digestive health, smoking cessation, eye care, and other products under the Tylenol, Motrin, Benadryl, Nicorette, Zarbee's, ORSLTM, Rhinocort, Calpol, and Zyrtec brands.